statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Precigen adds to disease awareness calendar with day dedicated to recurrent respiratory papillomatosis
apark
Fri, 03/29/2024 - 10:48...

Precigen adds to disease awareness calendar with day dedicated to recurrent respiratory papillomatosis

Precigen and Recurrent Respiratory Papillomatosis Foundation to Hold Inaugural International RRP Awareness Day on June 11th Precigen and Recurrent Respiratory Papillomatosis Foundation to Hold...

Precigen and Recurrent Respiratory Papillomatosis Foundation to Hold Inaugural International RRP Awareness Day on June 11th

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Precigen participates in a conference call with Cantor Fitzgerald

HC Wainwright reissued their buy rating on shares of Precigen (NASDAQ:PGEN  Free Report) in a research report report published on Wednesday, Benzinga reports. They currently have a $6.00 price...

Precigen (NASDAQ:PGEN) Receives Buy Rating from HC Wainwright

Precigen just downgraded at JPMorgan, here's why

Precigen (NASDAQ:PGEN  Get Free Report)s stock had its buy rating reissued by investment analysts at HC Wainwright in a note issued to investors on Wednesday, Benzinga...

HC Wainwright Reaffirms "Buy" Rating for Precigen (NASDAQ:PGEN)

J.P. Morgan cuts Precigen to underweight, cites burn rate...

J.P. Morgan cuts Precigen to underweight, cites burn rate

Precigen, Inc. (NASDAQ:PGEN  Free Report)  Stock analysts at HC Wainwright issued their Q1 2025 earnings per share estimates for shares of Precigen in a research note issued on...

Precigen, Inc. to Post Q1 2025 Earnings of ($0.05) Per Share, HC Wainwright Forecasts (NASDAQ:PGEN)

Precigen, Inc. (PGEN) Q4 2023 Earnings Call Transcript...

Precigen, Inc. (PGEN) Q4 2023 Earnings Call Transcript

Challenges Persist as Total Revenues Decline by 76.9% Year-Over-YearRelated Stocks: PGEN...

Precigen Inc (PGEN) Reports Full Year 2023 Financial Results

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the following segments: Biopharmaceuticals, Exemplar, and Trans Ova. The Biopharmaceuticals segment is involved in advancing the next generation of gene and cell therapies using precision technology to target urgent and intractable diseases in immuno-oncology, autoimmune disorders, and infectious diseases. It also engages in pioneering a proprietary class of microbe-based biopharmaceuticals that enable expression and local delivery of disease-modifying therapeutics. The Exemplar segment is focused on developing research models and services for healthcare research applications. The Trans Ova segment provides bovine reproductive technologies. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Volume	568,981.00
52-Wk High	$1.88
52-Wk Low	$0.8354

PGEN Precigen Inc

About

Feed

News

Sentiment

Earnings

Fundamentals